208 related articles for article (PubMed ID: 18798700)
1. Dose calculation of anticancer drugs.
Gao B; Klumpen HJ; Gurney H
Expert Opin Drug Metab Toxicol; 2008 Oct; 4(10):1307-19. PubMed ID: 18798700
[TBL] [Abstract][Full Text] [Related]
2. Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
Gurney H
J Clin Oncol; 1996 Sep; 14(9):2590-611. PubMed ID: 8823340
[TBL] [Abstract][Full Text] [Related]
3. Flat-fixed dosing versus body surface area based dosing of anticancer drugs in adults: does it make a difference?
Mathijssen RH; de Jong FA; Loos WJ; van der Bol JM; Verweij J; Sparreboom A
Oncologist; 2007 Aug; 12(8):913-23. PubMed ID: 17766650
[TBL] [Abstract][Full Text] [Related]
4. Dosing strategies for anticancer drugs: the good, the bad and body-surface area.
Felici A; Verweij J; Sparreboom A
Eur J Cancer; 2002 Sep; 38(13):1677-84. PubMed ID: 12175683
[TBL] [Abstract][Full Text] [Related]
5. Practical treatment guide for dose individualisation in cancer chemotherapy.
Canal P; Chatelut E; Guichard S
Drugs; 1998 Dec; 56(6):1019-38. PubMed ID: 9878990
[TBL] [Abstract][Full Text] [Related]
6. Standardization of the body surface area (BSA) formula to calculate the dose of anticancer agents in Japan.
Kouno T; Katsumata N; Mukai H; Ando M; Watanabe T
Jpn J Clin Oncol; 2003 Jun; 33(6):309-13. PubMed ID: 12913086
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic drug monitoring for dose individualization of Cisplatin in testicular cancer patients based upon total platinum measurement in plasma.
Salas S; Mercier C; Ciccolini J; Pourroy B; Fanciullino R; Tranchand B; Monjanel-Mouterde S; Baciuchka-Palmaro M; Dupuis C; Yang C; Balti M; Lacarelle B; Duffaud F; Durand A; Favre R
Ther Drug Monit; 2006 Aug; 28(4):532-9. PubMed ID: 16885721
[TBL] [Abstract][Full Text] [Related]
8. Cancer Chemotherapy: The Case for Therapeutic Drug Monitoring.
Knezevic CE; Clarke W
Ther Drug Monit; 2020 Feb; 42(1):6-19. PubMed ID: 31568180
[TBL] [Abstract][Full Text] [Related]
9. [Role of individualized dosing in oncology: are we there yet?].
Joerger M
Praxis (Bern 1994); 2013 Dec; 103(1):33-9. PubMed ID: 24393821
[TBL] [Abstract][Full Text] [Related]
10. Body surface area as a determinant of pharmacokinetics and drug dosing.
Sawyer M; Ratain MJ
Invest New Drugs; 2001 May; 19(2):171-7. PubMed ID: 11392451
[TBL] [Abstract][Full Text] [Related]
11. [Anticancer drug dosing--pharmacogenomic biomarkers or body surface area?].
Lehne G; Bjørheim J; Saeter G
Tidsskr Nor Laegeforen; 2007 Apr; 127(8):1040-4. PubMed ID: 17457389
[TBL] [Abstract][Full Text] [Related]
12. [Practical control methods for the dose individualization of anticancer drugs].
Wang LY; Tang ZQ; Feng FY
Ai Zheng; 2002 Dec; 21(12):1382-5. PubMed ID: 12520753
[TBL] [Abstract][Full Text] [Related]
13. Review of therapeutic drug monitoring of anticancer drugs part 1--cytotoxics.
Paci A; Veal G; Bardin C; Levêque D; Widmer N; Beijnen J; Astier A; Chatelut E
Eur J Cancer; 2014 Aug; 50(12):2010-9. PubMed ID: 24889915
[TBL] [Abstract][Full Text] [Related]
14. Tailor-made chemotherapy for cancer patients.
van Warmerdam LJ
Neth J Med; 1997 Jul; 51(1):30-5. PubMed ID: 9260487
[TBL] [Abstract][Full Text] [Related]
15. [Anticancer drug dose individualisation: from body surface area to physiology].
Pétain A; Chatelut E
Bull Cancer; 2008 Oct; 95(10):895-901. PubMed ID: 19004718
[TBL] [Abstract][Full Text] [Related]
16. Application of pharmacokinetic modelling to the routine therapeutic drug monitoring of anticancer drugs.
Rousseau A; Marquet P
Fundam Clin Pharmacol; 2002 Aug; 16(4):253-62. PubMed ID: 12570013
[TBL] [Abstract][Full Text] [Related]
17. A framework for economic evaluation of therapeutic drug monitoring-guided dosing in oncology.
Erku D; Schneider J; Scuffham P
Pharmacol Res Perspect; 2021 Oct; 9(5):e00862. PubMed ID: 34546005
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy dosing part I: scientific basis for current practice and use of body surface area.
Kaestner SA; Sewell GJ
Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):23-37. PubMed ID: 17305252
[TBL] [Abstract][Full Text] [Related]
19. Practical guidelines for dose individualization of anticancer targeted drugs.
Sáez MI; Quero C; Trigo JM; Muros B; Alba E
Clin Transl Oncol; 2012 Nov; 14(11):812-9. PubMed ID: 23065600
[TBL] [Abstract][Full Text] [Related]
20. Dose banding as an alternative to body surface area-based dosing of chemotherapeutic agents.
Chatelut E; White-Koning ML; Mathijssen RH; Puisset F; Baker SD; Sparreboom A
Br J Cancer; 2012 Sep; 107(7):1100-6. PubMed ID: 22929884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
